GlassScriptPhysician profile
Elizabeth A Deed
NPI 1447208038
$2,569.87
in general payments reported to CMS, 2019-2025
27 companies · none reported in 2025
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $303 · 2020: $230 · 2021: $1,087 · 2022: $530 · 2023: $378 · 2024: $42.41.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $420.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $420.47 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $857.54 | 2019-2023 | Lo Loestrin Fe |
| Aspira Women'S Health INC | $302.49 | 2021 | |
| Evofem Biosciences, INC. | $171.72 | 2021-2023 | Phexxi |
| Myovant Sciences INC. | $128.70 | 2021-2022 | |
| Pfizer INC. | $122.38 | 2019-2022 | |
| Mayne Pharma Commercial LLC | $119.07 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $114.26 | 2019-2023 | |
| Davol INC. | $93.70 | 2023 | Arista Ah Flexitip |
| Hologic Sales and Service, LLC | $71.29 | 2019-2021 | |
| Astellas Pharma US INC | $64.01 | 2023-2024 | Veozah |
| Organon LLC | $53.93 | 2021-2023 | Nexplanon |
| Therapeuticsmd, INC. | $48.38 | 2019-2022 | |
| Mylan Pharmaceuticals INC. | $44.01 | 2020-2022 | |
| Shield Therapeutics INC | $43.68 | 2023 | Accrufer |
| Merck Sharp & Dohme LLC | $43.25 | 2019-2021 |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Becton, Dickinson and Company | $40.14 | 2022 | |
| Duchesnay USA Incorporated | $36.24 | 2019 | |
| Ethicon US, LLC | $32.47 | 2020 | |
| Exeltis, USA INC. | $31.03 | 2020-2022 | |
| Avion Pharmaceuticals | $30.75 | 2021-2022 | |
| Covidien LP | $23.45 | 2019 | |
| Medtronic, INC. | $19.30 | 2022 | |
| Scynexis, INC. | $17.85 | 2022 | |
| Molnlycke Health Care US, LLC | $15.88 | 2021 | |
| Agile Therapeutics, INC. | $15.17 | 2021 | |
| Allergan, INC. | $15.05 | 2020 | |
| Minerva Surgical, INC | $14.13 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Elizabeth Deed listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.